Patents by Inventor Victoria Nachum

Victoria Nachum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic heterocyclic spiro compounds
    Patent number: 9034891
    Abstract: There are provided certain bicyclic heterocyclic compounds that act as M1 muscarinic receptor modulators. Compositions containing these compounds and their use are also disclosed.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: May 19, 2015
    Assignee: ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH
    Inventors: Abraham Fisher, Nira Bar-Ner, Victoria Nachum
  • Bicyclic heterocyclic spiro compounds
    Patent number: 8673931
    Abstract: There are disclosed bicyclic heterocyclic spiro compounds; pharmaceutical compositions comprising these compounds; and methods for the treatment in a mammal of diseases and conditions which are susceptible to modulation of the M1 muscarinic receptor, including Alzheimer's disease, insulin resistance syndrome and type 2 diabetes. Other embodiments are also disclosed.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: March 18, 2014
    Inventors: Abraham Fisher, Nira Bar-Ner, Victoria Nachum
  • BICYCLIC HETEROCYCLIC SPIRO COMPOUNDS
    Publication number: 20130225624
    Abstract: There are provided certain bicyclic heterocyclic compounds that act as M1 muscarinic receptor modulators. Compositions containing these compounds and their use are also disclosed.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 29, 2013
    Inventors: Abraham FISHER, Nira BAR-NER, Victoria NACHUM
  • BICYCLIC HETEROCYCLIC SPIRO COMPOUNDS
    Publication number: 20110281903
    Abstract: There are disclosed bicyclic heterocyclic spiro compounds; pharmaceutical compositions comprising these compounds; and methods for the treatment in a mammal of diseases and conditions which are susceptible to modulation of the M1 muscarinic receptor, including Alzheimer's disease, insulin resistance syndrome and type 2 diabetes. Other embodiments are also disclosed.
    Type: Application
    Filed: January 26, 2010
    Publication date: November 17, 2011
    Inventors: Abraham Fisher, Nira Bar-Ner, Victoria Nachum